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Abstract
Retinitis pigmentosa (RP) is the leading cause of blindness with nearly two million people
affected worldwide. Many genes have been implicated in RP, yet in 30–80% of the RP
patients the genetic cause remains unknown. A similar phenotype, progressive retinal atro-
phy (PRA), affects many dog breeds including the Miniature Schnauzer. We performed clini-
cal, genetic and functional experiments to identify the genetic cause of PRA in the breed.
The age of onset and pattern of disease progression suggested that at least two forms of
PRA, types 1 and 2 respectively, affect the breed, which was confirmed by genome-wide
association study that implicated two distinct genomic loci in chromosomes 15 and X,
respectively. Whole-genome sequencing revealed a fully segregating recessive regulatory
variant in type 1 PRA. The associated variant has a very recent origin based on haplotype
analysis and lies within a regulatory site with the predicted binding site of HAND1::TCF3
transcription factor complex. Luciferase assays suggested that mutated regulatory
sequence increases expression. Case-control retinal expression comparison of six best
HAND1::TCF3 target genes were analyzed with quantitative reverse-transcriptase PCR
assay and indicated overexpression of EDN2 and COL9A2 in the affected retina. Defects in
both EDN2 and COL9A2 have been previously associated with retinal degeneration. In sum-
mary, our study describes two genetically different forms of PRA and identifies a fully pene-
trant variant in type 1 form with a possible regulatory effect. This would be among the first
reports of a regulatory variant in retinal degeneration in any species, and establishes a new
spontaneous dog model to improve our understanding of retinal biology and gene regulation
while the affected breed will benefit from a reliable genetic testing.
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Author summary
Retinitis pigmentosa (RP) is a blinding eye disease that affects nearly two million people
worldwide. Several genes and variants have been associated with the disease, but still 30–
80% of the patients lack genetic diagnosis. There is currently no standard treatment for
RP, and much is expected from gene therapy. A similar disease, called progressive retinal
atrophy (PRA), affects many dog breeds. We performed clinical, genetic and functional
analyses to find the genetic cause for PRA in Miniature Schnauzers. We discovered two
forms of PRA in the breed, named type 1 and 2, and show that they are genetically distinct
as they map to different chromosomes, 15 and X, respectively. Further genetic, bioinfor-
matic and functional analyses discovered a fully penetrant recessive variant in a putative
silencer region for type 1 PRA. Silencer regions are important for gene regulation and we
found that two of its predicted target genes, EDN2 and COL9A2, were overexpressed in
the retina of the affected dog. Defects in both EDN2 and COL9A2 have been associated
with retinal degeneration. This study provides new insights to retinal biology while the
genetic test guides better breeding choices.
Introduction
Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinopathies with varying
genetic background and highly variable clinical consequences. RP is the leading cause of irre-
versible blindness in man with a worldwide prevalence of one in 4,000 people [1]. The disease
first manifests as impaired vision in dim light (nyctalopia) resulting from progressive loss of
the rod photoreceptor cells. As the disease progresses, complete blindness is expected due to
cone photoreceptor degeneration accompanied by changes in the retinal pigment epithelium
(RPE), the retinal vasculature, the glial cells and neurons of the inner retina. To date, 67 genes
and loci have been implicated to nonsyndromic RP according to the Retinal Information Net-
work RetNet (http://sph.uth.edu/retnet/) [2]. In the majority of cases, the mode of inheritance
is autosomal recessive, although some autosomal dominant and X-linked RP exist [2]. Despite
a large number of implicated genes and variants, 30–80% of the patients have RP of unknown
genetic cause and thus many genes remain still to be discovered [3].
RP is incurable at the moment and much is expected from gene therapy to treat this disease.
Different eye diseases have been favorite targets of gene therapy for several reasons, including
relatively easy access to treat and monitor the target organ. A recent study described patient
derived induced pluripotent stem cell (iPSC) treatment with clustered regularly interspersed
short palindromic repeats (CRISPR/Cas9) to treat a RP affected patient with an X-linked point
mutation in the retinitis pigmentosa GTPase regulator (RPGR) gene [4] in addition to other
attempts to treat retinal dystrophies. As a known genetic cause of disease is obligatory to any
gene therapy and still many RP related genes remain unknown, continuous attempts are
needed to discover new causative variants and understand the underlying biology.
The domestic dog (Canis familiaris) has emerged as a powerful model to study human
inherited diseases as its unique genetic architecture facilitates gene discoveries and many
inherited diseases occur spontaneously in different breeds [5]. More than 220 genes have been
implicated in various conditions over the past few years (www.OMIA.org) and the discovery
rate is expected to remain high due to higher-resolution approaches and available genomic
tools combined with the growing canine DNA biobanks worldwide [6,7]. Importantly, the dog
presents an excellent model for human eye diseases, as the canine ocular globe bears more
resemblance to the human eye, both anatomically and physiologically, than the eyes of the
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commonly used model organisms such as the mouse (Mus musculus) or the rabbit (Oryctola-
gus cuniculus) [8,9].
A similar phenotype to RP affects many dog breeds and is referred to as progressive retinal
atrophy (PRA) [10,11]. Clinical findings in PRA include gradual loss of vision, tapetal hyperre-
flectivity and attenuation of the retinal blood vessels, which result from the degeneration of the
photoreceptor layer in the retina–the pathology has great similarities to RP [10,12]. PRA affects
over 100 dog breeds and currently 19 genes and 24 variants in 58 dog breeds have been impli-
cated [13]. As with RP, the majority of the PRA related gene variants are autosomal recessive
[13], but one dominant [14] and three X-linked variants [15–18] have been reported as well. In
many dog breeds the causative variants have remained unknown, including the Miniature
Schnauzers (MSs) in which the clinical findings have been previously described while the
genetic background is undefined [19–22]. Recently, a genetic association was reported between
a variant in PPT1, a well-known candidate gene for neuronal ceroid lipofuscinosis (NCL), and
PRA in MS [23]. However, as the reported variant was incompletely penetrant (0.79) and as
the affected MSs did not present with neurological signs seen in the NCL patients [23], the
true causality of the variant remains elusive.
With a series of clinical, genetic, bioinformatic and biochemical experiments, we describe
here two genetically different forms of retinal degeneration in the MS breed mapping to chro-
mosomes 15 and X. We identify a novel fully penetrant recessive silencer variant in chromo-
some 15 with a possible gain-of-function effect resulting in overexpression of two retinal target
genes, EDN2 and COL9A2. Our results provide a new spontaneous dog model for retinal
pathophysiology and insights to retinal biology and gene regulation. The affected breed will
benefit from a genetic test for veterinary diagnostics and breeding advice.
Results
Ophthalmologic examinations reveal two types of retinopathy
To examine the PRA status of the study group of 85 MSs, careful eye examinations were per-
formed with inclusion criteria for cases being bilateral PRA findings with tapetal hypo- and
hyperreflectivity, vessel attenuation and pale optic nerve heads. The control dogs were free of
any eye diseases at the age of seven years or older. This phenotyping approach resulted in a
cohort of 18 cases and 67 controls. The clinical findings categorized the affected dogs to two dis-
tinctive groups: 12 dogs were diagnosed with severe PRA findings including total blindness
before the age of five years (defined as type 1 in this study) while six of the cases had milder
symptoms, slower progression with some visual capacity left at the time of examination and an
average age of onset seven years. Of the type 1 affected dogs, five were females and seven males.
Of the type 2 cases, only one was female while five were males, suggesting a possible sex-predis-
position or X-linked mode of inheritance. Control group included 33 female and 34 male MSs.
To evaluate the photoreceptor degeneration more precisely, OCT imaging was performed
to a clinically blind, type 1 PRA case. The imaging showed complete loss of the photoreceptor
layer (Fig 1) and thus confirmed the diagnosis. The clinical findings and the age of onset of the
type 1 cases closely resemble the results of the previous study [22]. Type 2 dogs were not avail-
able for the OCT study.
Genome-wide association study confirms two genetically distinctive types
of PRA in MS
A pedigree was drawn around the 18 affected dogs suggesting a recessive mode of inheritance,
as affected dogs were born to unaffected parents (Fig 2). To map the disease associated
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chromosomal region, a genome-wide association study (GWAS) was conducted first with 16
cases (including 10 type 1 and six type 2 cases) and 33 controls. This analysis suggested a PRA
locus on the canine chromosome 15 (praw = 4.70x10
-6, pgenome = 0.19, λ = 1, S1A Fig). In-depth
analysis of the genotypes in the locus showed that all of the type 1 cases shared a homozygous
haplotype block of 7.2 Mb from 213,416 bp to 7,403,217 bp that was present neither in the 32
out of 33 control dogs nor in any of the type 2 cases. This result supports the hypothesis of the
presence of two genetically distinct types of PRA in the MS breed. Interestingly, the homozy-
gous risk haplotype block was present also in one control dog (S1B Fig). As all the other con-
trol dogs, this one had been eye examined at seven years of age without any clinical signs of
PRA, suggesting either incomplete penetrance of the risk haplotype, or that the causative vari-
ant is recent and not all the risk haplotype carrying dogs have it.
We then analyzed the genotyping data of the two PRA types separately. When comparing
only the type 1 cases (n = 10) to the control dogs (n = 33), the same CFA15 locus and homozy-
gous haplotype block was associated (Fig 3A and 3B), but with a stronger statistical signifi-
cance (praw = 2.08x10
-9, pgenome = 2.40x10
-4, λ = 1.17). In addition, comparison of the type 2
cases (n = 6) and controls (n = 33) suggested an association to chromosome X (praw = 7.06x10
-
7, pgenome = 0.17, λ = 1.19), compatible with the suggested X-chromosomal sex pattern. In this
locus, three of the six affected dogs shared a homo- or hemizygous haplotype block of 15.4 Mb
from 38,294,920 bp to 53,726,107 bp that was absent in the controls and the rest of the type 2
cases (Fig 3C and 3D). As the number of type 2 cases was small, replication of the GWAS result
in chromosome X in a larger sample cohort is needed to confirm the locus before further
genetic analyses are performed. RPGR, the known canine PRA gene in CFAX, is not located in
the preliminary locus [15–18].
Whole-genome sequencing reveals four candidate variants
To identify the disease-causing variant in the associated chromosomal region for type 1 PRA
in MSs, we performed whole-genome sequencing on three MSs including two type 1 cases
with the risk haplotype and one control with opposite haplotype. In total, 467,778,694–
512,026,483 reads were collected of which 99.5% were mapped to the reference sequence. Over
97% of the reference had >10X coverage while the mean read depths were 29–31. Filtering was
done under recessive model, i.e., assuming that the cases were homozygous for the variant and
at least 99% of the controls homozygous for the reference allele. The controls included one MS
described above and 267 dogs of various breeds and without the studied phenotype (S1 Table).
Of the controls, 141 were whole-genome sequenced and available also for a mobile element
Fig 1. PRA confirmation by optical coherence tomography (OCT). OCT assessment of a healthy control (left hand side) and a four-year-old MS with severe
type 1 PRA findings (right hand side). Whole retinal (a) and photoreceptor inner and outer segment and outer nuclear layer thickness (b) measurement
showed total loss of the photoreceptor cell layers in the affected dog (orange arrow).
https://doi.org/10.1371/journal.pgen.1008659.g001
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insertion (MEI) analysis, while 127 where exome-sequenced and therefore available only for
analyzing single nucleotide variants and small insertions and deletions.
The two type 1 cases shared 2,149,016 common homozygous variants. After filtering against
control dogs, 5,235 variants were left, of which 233 resided in the CFA15 locus (S2 Table). Of
these, two were located in exons and two in splice sites (Table 1). These four variants were vali-
dated in the study cohort of 18 cases, including 12 type 1 PRA cases, and 67 control MSs. All
the type 1 cases were homozygous for all the four variants, indicating association between the
variants and the phenotype. However, there were also controls homozygous for the variants
(n = 4 for the variant in DLGAP3 and 2 for the other three variants), indicating either incom-
plete penetrance or that none of these variants are truly causative. We screened also the
recently published variant in PPT1 [23] in the cohort, although it was not caught by filtering.
All type 1 cases were homozygous for the variant, while five type 2 cases were wild-type and
one heterozygous. Of the 67 control dogs, 41 were wild-type, 22 heterozygous and four homo-
zygous, accounting for an association between the type 1 disease and the PPT1 variant
(p = 1.6x10-13). However, this association was 10 to 100 times weaker than that with the other
four variants in the same cohort (Table 1). MEI analysis revealed altogether 12 shared homozy-
gous variants in the two cases in the locus, but none of them proved case-specific after filtering.
No case-specific large structural variants were detected when analyzing the locus with IGV.
Sequencing an obligate carrier reveals a fully segregating regulatory variant
The whole-genome sequencing results together with the fact that one of the control dogs in
GWAS carried also the homozygous risk haplotype suggested that the causative variant for
type 1 PRA in MSs is recent and not all the risk haplotype carrying dogs have it. To test this
Fig 2. Pedigree of the study cohort. Pedigree analysis suggests a recessive mode of inheritance as affected dogs were born to unaffected parents. Squares indicate
males and circles females. Individuals marked with black are type 1 cases, while type 2 cases are marked with red. Dogs with yellow background were genotyped
and included in GWA study. Black arrows mark the whole-genome sequenced dogs.
https://doi.org/10.1371/journal.pgen.1008659.g002
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hypothesis, we performed whole-genome sequencing to an additional control MS, which was
homozygous for all the four previously validated variants, but was unaffected still at the age of
10 years. In addition, this dog had a type 1 PRA affected offspring and thus was an obligate
Fig 3. Mapping PRA loci in MSs. (A) Genome-wide comparison of allele frequencies in type 1 cases (n = 10) and controls (n = 33)
indicated a locus on the CFA15 (praw = 2.08x10
-9, pgenome = 2.40x10
-4). (B) A shared homozygous haplotype block was seen in all the
type 1 cases and one control and absent in 32/33 controls. Each row represents a single animal while genotypes at each SNP (columns)
are marked with light (homozygous), dark (opposite homozygous) or intermediate (heterozygotes) grey. The critical region of 7.2 Mb
spans from 213,416 bp to 7,403,217 bp and upper and lower limits of it were determined by appearance of heterozygous SNPs in the
case dogs. (C) GWAS in type 2 cases (n = 6) and controls (n = 33) suggests a locus on CFAX (praw = 7.06x10
-7, pgenome = 0.17). (D) A
shared homo- or hemizygous haplotype block of 15.4 Mb (spanning nucleotides 38,294,920–53,726,107 bp) is present in 3 out of 6 type
2 cases and absent in the controls and the rest of the type 2 cases.
https://doi.org/10.1371/journal.pgen.1008659.g003
PLOS GENETICS Putative silencer variant in canine retinitis pigmentosa model
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008659 March 9, 2020 6 / 20
carrier for the causative variant (Fig 2). Altogether 456,191,937 reads were collected of which
99.3% were mapped to the reference sequence. Over 97% of the reference had>10X coverage
and the mean read depth was 28. Filtering was performed as described above but by defining
this sample as an obligate carrier. This approach reduced the case-specific variant list to five
candidates including one intronic and four intergenic variants (Table 2). Three of the five vari-
ants appeared to be miscalled during validation by Sanger sequencing and IGV visualization.
The two variants left, an intergenic 5-bp deletion (g.1,887,878_1,887,882del) and an intronic
SNV (g.1,432,293G>A) in the transcription factor encoding the ortholog of human immuno-
deficiency virus type I enhancer binding protein 3 gene (HIVEP3, Fig 4A and 4B) were validated
in the study cohort of 18 cases and 67 controls. Again, all type 1 cases were homozygous for
both of the variants. The intergenic 5-bp deletion was found to be homozygous in 12 of the 67
control dogs, thus excluding it from further analysis. The variant in HIVEP3, however, indi-
cated complete penetrance as out of the 67 controls, 58 were wild-type, nine heterozygous and
none homozygous. Thus, this variant segregated completely with the disease and the associa-
tion with the type 1 phenotype was more than 10 billion times stronger than any other variants
in the region (p = 4.0x10-25).
HIVEP3 has been reported to be expressed ubiquitously, including the human retina, but it
has not been implicated to retinal disease in any species [25]. The canine HIVEP3
(XM_003431951.4) spans from 1,302,964 to 1,626,834 bp and includes 12 exons with protein
coding sequence in exons 6–12 (Fig 4A). The associated variant in HIVEP3 is located in the
third intron: 105,943 bp downstream to the third and 32,572 bp upstream to the fourth
untranslated exon. The surrounding sequence is ultraconserved (Fig 4B and 4C). There is also
a predicted dog-specific long non-coding RNA (lncRNA) ENSCAF00000035604 at the variant
locus (Fig 4). This lncRNA is antisense to HIVEP3 and consists of two exons and an intron.
Table 1. Coding or splicing variants resulting from filtering the whole-genome sequencing data did not segregate with the phenotype.
Position (bp)a Ref. allele Alt. allele Gene Variant type Variant (protein) Transcript p-valueb
603,169 T C C15H1orf50 nonsynonymous SNV p.M1V XM_539558.4 2.1x10^-15
603,940 G C P3H1 splicing (c.477+13G = C) - XM_843477.4 2.1x10^-15
2,064,277 C T SLFNL1 splicing (c.852+7C = T) - XM_022427740.1 2.1x10^-15
7,077,805 CACCAC del DLGAP3 nonframeshift deletion p.227_228del XM_014119248.2 7.0x10^-14
aCoordinates refer to the CanFam 3.1 annotation.
bAssociation of the variant with type 1 PRA in initial study cohort of 85 MSs
https://doi.org/10.1371/journal.pgen.1008659.t001
Table 2. Applying an obligate carrier to filtering decreased the number of variants to five, of which the intronic variant in HIVEP3/ENSCAFG00000035604 had
complete penetrance and strong association with the type 1 PRA in MSs.
Position (bp)a Ref. allele Alt. allele Variant type Gene
223,405 C del intergenic� ENSCAFG00000039839–ENSCAFG00000002484
405,398 A C intergenic� ENSCAFG00000002491–ENSCAFG00000040650
1,432,293 G A intronic HIVEP3, ENSCAFG00000035604
1,887,878 AAAAT del intergenic ENSCAFG00000038329–SCMH1
3,716,531 TTTCTT del intergenic� MACF1–NDUFS5
aCoordinates refer to the CanFam 3.1 annotation.
�Miscalled, excluded by Sanger sequencing and IGV.
https://doi.org/10.1371/journal.pgen.1008659.t002
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The variant is located 32,566 bp downstream of the first and 42,855 bp upstream to the second
exon.
To further validate the intronic variant in HIVEP3 in the MS breed, we genotyped all the
available MS samples (n = 514) from our dog DNA bank, including three additional PRA cases
and 118 dogs that were examined to have healthy eyes at the age of five or older. Of these, 456
Fig 4. Schematic representation of the variant (g.1,432,293G>A) site and RT-qPCR results of HAND1::TCF3
target genes. (A) The HIVEP3 and ENSCAFG00000035604 gene structures with coding regions indicated in dark and
non-coding in light green. The intronic variant (red) is located kilobases away of the exon-intron boundaries in both
genes. (B) Sanger chromatograms showing the DNA sequence in wild-type, carrier and homozygous dogs with the
mutated nucleotide marked with red background. (C) Alignment of different mammalian species showed that the
sequence surrounding the variant site is highly conserved, but the variant nucleotide itself (highlighted in red) is not.
JASPAR motif scanning indicated that TFBS of HAND1::TCF3 overlaps exactly the variant site (highlighted in yellow).
(D) RT-qPCR of retinal samples from a type 1 affected MS and four control retinal samples wild-type for the variant
and without the studied phenotype showed case-specific over-expression of EDN2 and COL9A2. The comparative
ΔΔCT method was used to determine relative expression [24] and error bars are determined as standard deviation of
the mean ΔCT.
https://doi.org/10.1371/journal.pgen.1008659.g004
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(88.7%) were wild-type, 55 (10.7%) heterozygous and three (0.58%) homozygous for the vari-
ant. The identified three homozygotes were the PRA cases in the breed screening cohort and
were clinically identical to type 1 cases as described above. These results in the breed screening
cohort indicate again a complete penetrance of the intronic variant in HIVEP3 and strong
association with the type 1 phenotype (p = 8.7x10-13). Combining the results of the initial
study cohort and the breed screening cohort resulted in a very strong association (p = 1.1x10-
42) with the type 1 phenotype and was the only one of the validated variants with complete
penetrance. The variant was not found from 735 genomes of different breeds available through
The Dog Biomedical Variant Database Consortium dataset, which agrees with our hypothesis
of a recent variant. No variants in the corresponding position in the human genome have been
reported in the Genome Aggregation Database gnomAD [26].
Associated variant is located within a putative silencer with HAND1::TCF3
transcription factor binding motif
The sequence surrounding the variant site is ultraconserved (Fig 4C), suggesting functional
importance. The possible effect of the intronic variant on the splicing of the HIVEP3 and
lncRNA ENSCAFG00000035604 transcripts was investigated by Sanger sequencing the retinal
cDNAs from a case dog homozygous for the variant but indicated no changes compared to the
wild-type transcript and thus ruled out splicing defects.
To further explore the functional significance of the associated variant, the syntenic site in
the human genome was investigated, revealing that the variant is located in a peak of ENCODE
DNaseI hypersensitivity cluster, which indicates an open chromatin environment and a possi-
ble regulatory site [27]. To gather further evidence, we next explored the JASPAR database to
search for transcription factor binding sites (TFBSs) that could bind the sequence in the vari-
ant site. This search resulted in the discovery of a putative HAND1::TCF3 complex TFBS,
overlapping exactly the variant location (Fig 4C).
The possible regulatory function was studied by performing a dual luciferase reporter assay
in MDCK cells transfected with wild-type, mutant, or empty vector constructs (S3 Table). The
wild-type and mutant constructs contained 250 bp of upstream and downstream sequences
from the variant site. Relative luciferase activity was significantly lower in cell lines transfected
with the wild-type than with the empty vectors (p< 0.05, Fig 5), thus indicating silencer activ-
ity in the variant site. The PRA associated variant seems to disrupt the silencer activity as the
cells transfected with the mutant constructs showed significantly higher reporter gene expres-
sion compared to the cells with the wild type constructs (p< 0.05, Fig 5).
Retinal overexpression of EDN2 and COL9A2 in the affected dog
We next investigated whether the silencer variant has any effect on the expression of its target
genes. Quantitative reverse-transcriptase PCR (RT-qPCR) with retinal samples from a type 1
PRA case and four unaffected dogs (wild-types for the variant) was performed for a selected
set of target genes. As silencers can act from a distance, the presence of the HAND1::TCF3
motif was screened in the promoters of the flanking genes +/- 1.25 Mb from the variant site.
Altogether 714 predicted HAND1::TCF3 binding sites were found in the promoter regions in
60 genes (S4 Table). Due to limited amount of available case-specific retinal RNA, six candi-
date genes were prioritized, including HIVEP3, lncRNA (ENSCAFG00000035604), COL9A2,
EDN2, KCNQ4 and NFYC. Prioritization was based on the motif scanning score, known
expression in retinal tissues in FANTOM5, Human Protein Atlas data [28,29] and retinal
expression data from our STRT sequencing data from five dogs (S2 Fig and S4 Table). The RT-
qPCR results indicated that retinal expression of EDN2 was increased by over 16-fold
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(p = 0.0023) and COL9A2 by over 4-fold (p = 0.049). Retinal expression of KCNQ4 was
increased by over 10-fold in the case retina, but the change was not statistically significant
(p = 0.065), because of the large differences between retinal samples of the right and left eyes of
the affected MS. Retinal NFYC expression was also not significantly changed (p>0.05). Given
the lack of retinal tissues from additional affected and control MSs and to test the tissue-speci-
ficity of the regulatory sequence, we collected skin biopsies from three variant homozygotes,
two carriers and three wild-type MSs and analyzed the potential differential expression of the
60 predicted target genes for HAND1::TCF3 by STRT. Out of the 60 genes, none were
expressed in skin (S3 Fig), preventing us to compare the possible effect of the alternate geno-
types on the transcript levels. It is likely that our candidate variant lies in a retina-specific regu-
latory region, which is supported also by the lack of extra-ocular phenotypes in the affected
dogs.
Discussion
RP is the leading cause of blindness in humans and nearly 70 genes have been implicated in
various forms of the disease. However, the genetic origin remains still elusive in many cases
Fig 5. Reporter assay indicates the variant site might be a silencer. Dual luciferase assay with MDCK cells transfected with wild-type
(WT), mutant (MT) and empty vectors indicated robust reduction in relative luciferase activity when comparing the wild-type
constructs to empty vector, supporting the putative silencer activity (p< 0.05). Relative luciferase activity was significantly increased in
mutant versus wild-type constructs (p< 0.05), indicating the type 1 PRA associated variant disrupts the putative silencer activity, but
might not prevent it completely.
https://doi.org/10.1371/journal.pgen.1008659.g005
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[3]. We report here clinical and genetic characterization of a canine RP model (PRA), which
provides new insights into the accumulating evidence of regulatory variants in the develop-
ment of retinal disease.
The key findings of the study have several scientific and medical implications. We demon-
strate the presence of at least two clinically and genetically different forms of PRA in the MS
breed. The type 1 PRA with a homogeneous onset at 4 years of age mapped to chromosome
15, while the type 2 PRA, with an overrepresentation of affected males and a wider range of
age of onset, mapped to chromosome X. While the tentative association in chromosome X
needs to be replicated with additional cases, the association of the type 1 PRA in chromosome
15 was very strong. The origin of the causative variant was suspected to be very recent, since
the homozygous risk haplotype was also present in unaffected dogs. Sequence analyses in the
7.2-Mb critical region associated with the type 1 PRA revealed a number of possibly patho-
genic coding variants, however, all of them had incomplete penetrance (~70%). The incom-
plete penetrance of the many coding variants was consistent with the suspected recent origin
of the actual causative variant. Indeed, the only fully penetrant variant located in the intron of
HIVEP3 transcription factor and a lncRNA ENSCAFG00000035604, however, kilobases away
from any predicted splice sites. However, the expression of neither HIVEP3 nor lncRNA
(ENSCAFG00000035604) was significantly changed in the affected retina. Consistently, in sil-
ico analyses of the variant site predicted a binding site of the HAND1::TCF3 TF complex, sug-
gesting a regulatory variant. Luciferase assays demonstrated an increased transcriptional
activity of the reporter gene in the mutant recombinant, suggesting a gain-of-function variant
in a silencer sequence. Silencer hypothesis was further supported by the observed overexpres-
sion of EDN2 and COL9A2 in the affected retina. Transcriptional regulation is often tissue-spe-
cific as observed also in this case with experiments in the skin biopsies and lack of extra-ocular
phenotypes.
Altogether, these results suggest a loss-of-cell identity hypothesis: the identified regulatory
variant affects a tissue-specific silencer and results in the upregulation of retinal gene expres-
sion, which in turn leads to the loss of cell- or tissue-specific identity and ultimately result in
the degeneration of the photoreceptor cells. Similar mechanism has been reported for a regula-
tory variant in the GRHL2 gene in posterior polymorphous corneal dystrophy type 4 [30]. The
proposed hypothesis is of particular interest, as the retinal phenotype in the MS breed was
originally described a dysplastic disease leading to degeneration, and the clinical findings in
our type 1 PRA affected MS group fully mimic the reported dysplasia [31]. However, further
studies with larger canine retinal sample sets are needed to confirm the functional aspects of
the variant. In addition, chromatin immunoprecipitation and EMSA gel shift assays are
required to formally confirm the silencer function and its binding repressor(s), which would
though need the development of dog-specific reagents.
Although our conclusions about the disease mechanisms are limited because of access to
only one set of affected retinas from an 11-years-old type 1 affected MS, and should be therefore
interpreted very cautiously, some discussion about the two target genes is warranted. EDN2
encodes endothelin-2, which has been implicated in various cellular functions such as angiogen-
esis, cell migration, cell proliferation, and endothelial activation [32–36]. Overexpression of
Edn2 in the mouse retina inhibits retinal vascular development [37], which might also explain
the etiology of the disease in MS type 1 cases as attenuation of retinal vessels is a hallmark fea-
ture in canine PRA [10] and was also observed in the cases here. However, EDN2 overexpres-
sion might also function as a general stress signal from photoreceptor damage, and therefore it
cannot be distinguished here, whether the observed overexpression of EDN2 reflects the pri-
mary etiology of the retinal degeneration in type 1 PRA or the secondary stress reaction to the
photoreceptor damage [32,38]. A loss-of-function variant in COL9A2 has been associated to
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autosomal recessive Stickler syndrome, in which vitreoretinal degeneration is one of the symp-
toms together with other ocular, auditory, skeletal and orofacial abnormalities [39].
Besides providing new insights into the possible disease mechanisms related to the under-
represented regulatory variants, our findings have important implication to the veterinary
diagnostics and breeding programs. Recently, a complex structural variant in PPT1 was pro-
posed to cause PRA in MS [23]. This study, using lower resolution genotyping array, found a
suggestive GWAS signal on the CFA15 with a ~5Mb critical interval that some, but not all,
cases shared. Whole-genome sequencing approach identified the same intronic HIVEP3 vari-
ant described here, but its potential functional role was not studied and the focus was turned
to the complex structural variant in PPT1 as it was homozygous in some of the affected dogs
that were wild-type or heterozygous for the HIVEP3 variant. Additional screening found also
some of the controls to be homozygous for the PPT1 variant, accounting for a penetrance of
79% [23]. In contrast, our data shows that the breed is affected with multiple genetically dis-
tinct forms of PRA and that the causative variant has such a recent origin that not all risk hap-
lotype-carrying dogs have it. This leads to the identification of many candidate variants in the
critical interval that seem to, misleadingly, associate with the phenotype, but have incomplete
penetrance. In contrast, in our cohort, the predicted silencer variant located in the HIVEP3
intron, has complete penetrance and 10 billion times stronger association with the type 1 PRA
as compared with the PPT1 variant in our study cohort. Our study provides a proper marker
for genetic testing avoiding unnecessary confusion within the breeding community.
To summarize, we have identified two forms of retinal degeneration in a dog breed and
showed that these phenotypes are distinct both clinically and genetically. We mapped two new
loci and identified a type 1 disease-specific recessive variant in a putative silencer located in
predicted HAND1::TCF3 TFBS with two of its target genes overexpressed in the affected retina
sample. These results establish the MS dog breed as a spontaneous large animal model to study




All dogs used in this study were privately owned pet dogs. EDTA blood samples (3 ml) from
all the dogs, skin biopsies from eight dogs and retinal samples from six dogs (euthanized
because of severe diseases, described in detail below) donated to research were collected under
the permission of animal ethical committee of County Administrative Board of Southern Fin-
land (ESAVI/343/04.10.07/2016) and all experiments were performed in accordance with rele-
vant guidelines and regulations and with owners’ written consent.
Study cohort
This study included altogether 599 privately owned purebred MSs, including a discovery
cohort of 85 dogs and a population screening cohort of 514 dogs. The discovery cohort
included 18 cases and 67 control dogs, which all were eye examined by veterinary ophthalmol-
ogists board-certified by the European College of veterinary ophthalmologists. The eye exami-
nation included basic neuro-ophthalmic examination, slit-lamp biomicroscopy to evaluate the
adnexa and anterior segment and indirect ophthalmoscopy to examine the posterior parts of
the eye. Topical tropicamide (Oftan Tropicamid 1%, Santen, Tampere, Finland) was used to
achieve mydriasis. Optical coherence tomography, OCT, (Heidelberg’s Spectralis, Heidelberg
Engineering GmbH, Heidelberg, Germany) was performed to one PRA affected MS. Inclusion
criteria for cases were bilateral severe PRA findings. Controls did not show any symptoms of
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eye disease and were minimum of seven years old at the time of the examination. Population
based variant screening was performed in 514 MSs of which three were affected with type 1
PRA and 118 were eye examined healthy at the age five or older by veterinary ophthalmologists
as described above. EDTA blood samples (3 ml) from all the dogs and tissue samples from six
euthanized dogs donated to research were collected under the permission of animal ethical
committee of County Administrative Board of Southern Finland (ESAVI/343/04.10.07/2016)
and all experiments were performed in accordance with relevant guidelines and regulations.
Genomic DNA was extracted from the white blood cells using a semi-automated Chemagen
extraction robot (PerkinElmer Chemagen Technologie GmbH, Baeswieler, Germany) accord-
ing to the manufacturer’s instructions. DNA concentrations were measured using Qubit fluo-
rometer (Thermo Fisher Scientific, Waltham, Massachusetts, USA) and Nanodrop ND-1000
UV/Vis Spectrophotometer (Nanodrop technologies, Wilmington, Delaware, USA) and sam-
ples were stored at –20˚C.
Genome-wide association study
A genome-wide association study, GWAS, was performed using Illumina’s CanineHD Bead-
Chip arrays with 172,963 markers (San Diego, CA, USA). Genotyping was performed in Gene-
Seek Laboratory (Neogen Genomics, Lincoln, NE, USA) to 16 cases and 33 controls. After
quality control procedures, only SNPs which conformed to Hardy-Weinberg expectations
P<0.0001, had >95% genotyping rate and minor allele frequency of>5% were included in the
analysis, resulting in the total number of 102,661 SNPs when analyzing all the cases and con-
trols and 100,501 and 102,286 when comparing separately the type 1 cases and type 2 cases to
controls, respectively. The differences in allele frequency between cases and controls were cal-
culated using the PLINK 1.07 software [40]. Corrected empirical p-values were calculated with
100,000 permutations and genomic control adjusted significance values based on the estima-
tion of the inflation factor.
Whole-genome sequencing
Whole genome sequencing was performed to two cases and two controls using the Illumina
HiSeq X ultra-high-throughput sequencing platform with 30X target coverage (paired-end
reads, 2x 150 bp) (Novogene Bioinformatics Institute, Beijing, China). Mapping the reads to
the dog reference genome (assembly CanFam 3.1) was performed using the Burrows-Wheeler
Aligner (BWA) version 0.7.15 [41]. The reads were sorted and duplicate reads marked using
the Picard tools (http://sourceforge.net/projects/picard). Post-alignment processing includes
local realignment around known INDELs and base quality scores recalibration to reduce erro-
neous variant calls [42]. Variant calling was done using the HaplotypeCaller in Genome Analy-
sis Tool Kit GATK version 3.7. Functional annotation of the variants was done in ANNOVAR
using Ensembl, NCBI and Broad gene databases. Mobile element insertions were detected in
the three whole-genome sequenced samples using the Mobile Element Locator Tool (MELT)
[43]. The reference sequences of the transposons for MEI discovery were retrieved from
Repbase database [44]. The detected variants were stored in Genotype Query Tools (GQT)
[45] variant database and variant filtering was performed using our in-house pipeline assum-
ing recessive mode of inheritance, i.e. the cases were homozygous for the alternative alleles.
The variant data from whole-exome (n = 127) and whole-genome sequenced (n = 140) dogs
without the studied phenotype and from various breeds were used in filtering as controls (S1
Table). A maximum of 1% of the controls were allowed to be heterozygotes of the alternative
allele, while the rest were set to be homozygous for the reference allele.
PLOS GENETICS Putative silencer variant in canine retinitis pigmentosa model
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008659 March 9, 2020 13 / 20
Sanger sequencing and TaqMan genotyping
Sanger sequencing was utilized to perform segregation analyses for the variants found in filter-
ing the whole-genome sequencing data. Segregation analysis of the PPT1 structural variant
was performed utilizing the consecutive markers (g.2,872,023_2,872,024del and
g.2,872,103G>A) confirmed to be consistent with the actual complex structural variant in the
original study [23] and which was also validated in our whole-genome sequenced MS samples.
All other variants were directly sequenced. Primers (S5 Table) were designed using the
Primer3 program [46] and PCR products amplified using Biotools DNA Polymerase (Biotools
B&M Labs, S.A., Valle de Tobalina, Madrid, Spain). The PCR products were treated with exo-
nuclease I and shrimp alkaline phosphatase and capillary sequenced in the Institute for Molec-
ular Medicine Finland (Helsinki, Finland). The Sanger sequence data were analyzed using
Sequencher 5.1 (Gene Codes Corporation, Ann Arbor, MI, USA) and Unipro UGENE 1.31.1
(UniPro, Novosibirsk, Russia). Variant screening in the MS breed cohort with 514 dogs was
performed using Custom TaqMan SNP Genotyping Assay (S5 Table) chemistry (Thermo-
Fisher Scientific, Waltham, MA, USA) and CFX96 Touch Real-Time PCR Detection System
(BioRad, Hercules, CA, USA).
In-silico analysis of transcription factor binding sites and target gene
prioritization
The UCSC liftOver tool was utilized to convert the corresponding variant site in the human
genome version GRCh38. The overlapping TFBS motif (HAND1::TCF3) was obtained from
the JASPAR database [47]. Motif scanning was done using “searchSeq” function of TFBSTools
package (v.1.20) under R programming language [48] on the +/-500 bp regions surrounding
the TSSs of CanFam3.1 Ensembl genes version 94 [49]. Target gene prioritization was per-
formed based on motif scanning score and confirming retinal expression in canine STRT
sequencing data and in the FANTOM5 [28] and the Human Protein Atlas [29] databases.
STRT RNA-sequencing was performed to retinal samples collected from five dogs: a 3-year-
old female Swedish Elkhound, 5- and 6-year-old male Rottweilers, a 6-year-old female Finnish
Lapphund and a 6-year-old male Border Collie that were all wild-type for the type 1 PRA asso-
ciated variant and without the studied phenotype. The dogs were privately owned pets. The
Swedish Elkhound and the Border Collie were euthanized because of epilepsy, the Rottweilers
due to gastrointestinal disease and the Finnish Lapphund due to intervertebral hernia. Samples
were collected within 15 minutes after death and treated with Invitrogen RNAlater Stabiliza-
tion Solution (Thermo Fisher Scientific, Waltham, Massachusetts, USA) for 24 hours and
stored in –80˚C. RNA was extracted using the RNeasy Mini Kit (Qiagen, Venlo, Netherlands)
according to manufacturer’s instructions. Integrity of RNA was evaluated with Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, California, USA) and concentration measured
with Qubit fluorometer (Thermo Fisher Scientific, Waltham, Massachusetts, USA) and Nano-
drop ND-1000 UV/Vis Spectrophotometer (Nanodrop technologies, Wilmington, Delaware,
USA). 20 ng of RNA was used for multiplex 48 sample RNA-seq libraries, which were prepared
using modified STRT method with unique molecular identifiers [50,51]. The modifications
included longer UMI’s of 8 bp, addition of spike-in ERCC control RNA for normalization of
expression, and use of Globin lock method [52] with LNA-primers for canine alpha- and beta-
globin genes. The libraries were sequenced with Illumina NextSeq 500, High Output (75
cycles). Reads were mapped to CanFam3.1 genome annotation using HISAT1 mapper version
2.1.0 [53]. Gene level quantification was done using featureCounts version 1.6.2 [54] and the
counts were then normalized to the library size and transcript length. The expression levels of
60 flanking genes (S4 Table) was then visualized using the ComplexHeatmap package [55].
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Dual luciferase reporter assay
To verify the predicted silencer role and to study whether the found variant has an effect on its
function, constructs containing the wild-type and mutated canine sequence (CanFam 3.1, 250
bp +/- of the variant site) were generated (S3 Table) and cloned into the pNL3.2[NlucP/minP]
NanoLuc luciferase vector (Promega, Madison, WI, US). The pGL4.54[luc2/TK] firefly lucifer-
ase was used as a co-transfection control vector (Promega, Madison, WI, US). For transfection
assay, 3 x 105 MDCK cells were seeded per well in 96 well cell culture microplate with white
walls (CellStar, Greiner bio-one, Germany) 24h prior to transfection, using Gibco Advanced
MEM medium (Thermo Fisher Scientific, Waltham, Massachusetts, USA) supplemented with
10% FBS, 100 U penicillin/streptomycin and Glutamax. Cell transfection was performed using
Lipofectamine3000 (Invitrogen, Carlsbad, US) according to manufacturer instructions. The
co-transfection was performed using 10 ng wild-type, mutated or empty experimental vector,
10 ng control vector and 90 ng carrier DNA per well. Luciferase activities were measured after
48 h using the Nano-Glo1 Dual-Luciferase1 Reporter Assay System (Promega, Madison,
WI, US) according to the manufacturer’s instructions and luminescence was detected using
the Enspire 2300 instrument (PerkinElmer Chemagen Technologie GmbH, Baeswieler, Ger-
many). Luminescence values were normalized by calculating the ratio between experimental
(NanoLuc) and control (firefly) reporter. Statistical significance of the results was assessed by
one-way ANOVA and Bonferroni approach as post-hoc test and p-value < 0.05 was consid-
ered significant. The assays were performed twice with 4 to 6 replicates per treatment.
Target gene expression analysis in retina and skin biopsies
Retinal samples from both eyes were collected from a 11-year old male MS affected with type 1
PRA and homozygous for the intronic variant in HIVEP3. Control retinal samples were col-
lected from a 2-year-old female German Pinscher, a 3-year-old female East-European Shep-
herd, a 5-year old male Smooth Collie and a 5-year-old male Rottweiler that were all wild-type
for the variant and without the studied phenotype. The dogs were privately owned pets. The
MS was euthanized because of congestive heart failure, the Rottweiler due to inflammatory
bowel disease and the German Pinscher, Smooth Collie and the East-European Shepherd due
to behavioral problems. Samples were collected and treated as were the ones used for the
STRT experiment described above. Reverse transcription from RNA to cDNA was performed
to equal amounts of sample RNA with High Capacity RNA-to-cDNA Kit (Applied Biosystems,
Waltham, Massachusetts, USA). Primer3 program [46] was used to design the primers (S4
Table) for the six target genes (HIVEP3, ENSCAFG00000035604, COL9A2, EDN2, KCNQ4,
NFYC) and the two house-keeping genes (GAPDH and YWHAZ), that were used as normali-
zation controls. Forward and reverse primers were positioned in different exons to avoid geno-
mic DNA contamination. Primer efficiencies were determined from a seven-point dilution
series and the comparative ΔΔCT method was used to determine relative expression [24]. Real-
time quantitative PCR (RT-qPCR) was performed with SsoAdvanced Universal SYBR Green
Supermix (BioRad Hercules, CA, USA) and the CFX96 Touch Real-Time PCR Detection Sys-
tem (BioRad, Hercules, CA, USA) according to manufacturer’s instructions. Three technical
replicates were used for all reactions. Error bars were determined as standard deviation of the
mean ΔCT.
Skin biopsies were collected from eight MSs including three PRA affected variant homozy-
gotes, two carriers and three wild-type dogs. Samples were taken from the dorsal neck region
with punch biopsy technique using local infiltration anesthesia with 2% lidocaine (Orion
Pharma, Espoo, Finland) and stored in RNAlater Stabilization Solution (Invitrogen, Thermo
Fischer Scientific, Waltham, Massachusetts, USA). RNA was extracted using the NucleoSpin
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RNA kit (Macherey-Nagel Gmbh, Germany) according to manufacturer’s instructions. RNA
concentration and integrity were measured as described above.
Supporting information
S1 Fig. Initial mapping approach for PRA locus in MSs. (A) Genome-wide comparison of
allele frequencies in all cases regardless of the disease type (n = 16) and controls (n = 33) sug-
gested a locus on the CFA15 (praw = 4.70x10
-6, pgenome = 0.19). (B) A shared homozygous hap-
lotype block was seen in all the type 1 cases and absent in all the type 2 cases and in 32/33
controls, indicating the two clinically distinct types are indeed genetically different. Interest-
ingly, the risk haplotype was also present in one of the confirmed controls, indicating either
incomplete penetrance of the risk haplotype, or that the causative variant is recent and not all
the risk haplotype carrying dogs have it. Each row represents a single animal while genotypes
at each SNP (columns) are marked with light (homozygous), dark (opposite homozygous) or
intermediate (heterozygotes) grey. The critical region of 7.2 Mb spans from 213,416 bp to
7,403,217 bp and upper and lower limits of it were determined by appearance of heterozygous
SNPs in the case dogs.
(TIF)
S2 Fig. Heat map from the canine retinal STRT sequencing experiment. Retinal samples
from five dogs wild-type for the type 1 PRA associated variant and without the studied pheno-
type were STRT sequenced to examine retinal gene expression of the 60 target genes for
HAND1::TCF3 TFBS. Columns indicate individual samples (SE = Swedish Elkhound,
RW = Rottweiler, FL = Finnish Lapphund, BC = Border Collie), rows each target gene. Darker
green color indicates stronger expression in the retina (TPM = transcripts per million). The six
genes prioritized by several factors for RT-qPCR were all expressed in the canine retina
(ENSCAFG00000002576, HIVEP3; ENSCAFG00000002827, NFYC; ENSCAFG00000035604,
lincRNA; ENSCAFG00000002579, EDN2; ENSCAFG00000002997, COL9A2;
ENSCAFG00000002814, KCNQ4).
(PDF)
S3 Fig. Heat map from the canine skin STRT sequencing experiment. Skin biopsies from
eight MS including two heterozygotes (orange), three variant homozygotes (red) and three
wild-type dogs (green) were collected and STRT sequenced to examine potential differences in
the expression levels of the 60 target genes. As a result, none of the target genes were expressed
in the skin.
(TIF)
S1 Table. Filtering the whole-genome sequencing data: Controls. Control dogs used for fil-
tering the whole-genome sequencing data (numbers per breed).
(XLSX)
S2 Table. Filtering the whole-genome sequencing data: Results. Filtering the whole-genome
data from two type 1 PRA cases against 268 controls resulted in 233 variants.
(XLSX)
S3 Table. Dual Luciferase reporter assay. The construct sequences used for MDCK cell trans-
fections.
(PDF)
S4 Table. Motif search results. Motif search found 714 predicted HAND1::TCF3 binding
sites (Sheet1) in the promoter regions (+/- 500 bp TSS) of 60 genes (Sheet2) flanking the
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variant site. The STRT-based retinal expression levels of the 60 genes in the ten dogs used in
the DoGA project (Sheet 3).
(XLSX)
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Funding acquisition: Maria Kaukonen, Hannes Lohi.
Investigation: Maria Kaukonen.
Methodology: Maria Kaukonen, Ileana B. Quintero, Abdul Kadir Mukarram, Kaisa Kyöstilä,
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